Horsburgh C R, Selik R M
AIDS Program, Centers for Disease Control, Atlanta, Georgia 30333.
Am Rev Respir Dis. 1989 Jan;139(1):4-7. doi: 10.1164/ajrccm/139.1.4.
We analyzed cases of disseminated nontuberculous mycobacterial infection (DNTM) in patients with AIDS reported to the Centers for Disease Control. Between 1981 and 1987, 2,269 cases were reported. In 96% of cases, infection was caused by M. avium complex (MAC). The number of cases has risen steadily since 1981, but the rate as a percentage of AIDS cases has remained stable at 5.5%. DNTM was seen less frequently in AIDS cases with Kaposi's sarcoma than in other AIDS cases (p less than 0.01). Rates of DNTM were lower in Hispanics and declined with age but were not significantly different by patient sex or means of acquiring HIV infection. Rates of disseminated MAC varied by geographic region from 3.9% to 7.8% (p less than 0.0001). As assessed by helper/suppressor T-cell ratios, AIDS patients with DNTM were not more immunologically impaired than those with other opportunistic infections. Life table analysis revealed that AIDS patients with DNTM survived a shorter time (median, 7.4 months) than did other AIDS patients (median, 13.3 months; p less than 0.0001). We conclude that DNTM is acquired by unpreventable environmental exposures. Because DNTM adversely affects survival of AIDS patients, effective therapeutic agents must be vigorously sought.
我们分析了向疾病控制中心报告的艾滋病患者播散性非结核分枝杆菌感染(DNTM)病例。1981年至1987年期间,共报告了2269例病例。96%的病例感染由鸟分枝杆菌复合群(MAC)引起。自1981年以来,病例数稳步上升,但作为艾滋病病例的百分比发病率一直稳定在5.5%。与其他艾滋病病例相比,卡波西肉瘤艾滋病病例中DNTM的发生率较低(p<0.01)。西班牙裔人群中DNTM的发病率较低,且随年龄增长而下降,但患者性别或感染HIV的途径对其发病率无显著差异。播散性MAC的发病率因地理区域而异,从3.9%到7.8%(p<0.0001)。通过辅助/抑制性T细胞比值评估,患有DNTM的艾滋病患者在免疫功能上并不比患有其他机会性感染的患者受损更严重。生命表分析显示,患有DNTM的艾滋病患者存活时间较短(中位数为7.4个月),而其他艾滋病患者存活时间较长(中位数为13.3个月;p<0.0001)。我们得出结论,DNTM是通过不可预防的环境暴露获得的。由于DNTM对艾滋病患者的生存产生不利影响,必须积极寻找有效的治疗药物。